Interestingly, clonal RBM10 loss of function has been associated with shorter survival in early-stage lung cancer patients43, while in our analysis subsequent evolution towards RBM10 mutations predicts favorable prognosis in metastatic samples, indicating that the timing of mutation acquisition during tumor history is relevant. This evidence concerns the gene RBM10 and lung carcinoma.